Key result
Recent conceptual, technical, and pharmacological strategies in coronary artery bypass grafting allow surgeons to adapt approaches to individual patients to improve early and late outcomes.
Recent conceptual, technical, and pharmacological strategies allow cardiovascular surgeons to adapt CABG procedures to individual patients, improving early and late outcomes.
Answers are grounded in this paper and cite their sources.
Supports individualized CABG strategies to improve outcomes; leaves open prospective validation before practice change.
During recent years, new conceptual, technical and drug strategies have led to improved early and late outcomes after coronary artery bypass surgery. These new strategies can be divided into the following three groups: optimisation of pre-operative patient selection and indications for and timing of the operation; peri-procedural refinements, including new techniques and instruments to avoid extracorporeal circulation, reduce aortic manipulation and minimise surgical access; and improvements to post-operative care, such as fast-track protocols and long-term drug therapy. In summary, the wide range of the surgical armamentarium available today allows cardiovascular surgeons to adapt the surgical strategy to individual patients and the given clinical scenario. This article aims to describe clinical rationales for the adoption of new concepts, provide an introduction to technical details and discuss clinical study results where appropriate.
No takes yet. Share an insight, caveat, or question.
Rastan et al. (2011) conducted a review in Coronary artery disease requiring bypass surgery. New conceptual, technical and drug strategies for CABG was evaluated. Recent conceptual, technical, and pharmacological strategies in coronary artery bypass grafting allow surgeons to adapt approaches to individual patients to improve early and late outcomes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: